CP 4 - intro to antifungal Flashcards

1
Q

what are the 3 types of fungi

A

1 - filamentous fungi
2- yeasts
3 - dimorphic fungi (in between 1 & 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are some of the 5 targets for antifungal drugs

A

DNA synthesis, mitosis, protein synthesis, cell membrane - ergosterol, cell wall - beta 1,3-glucan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is ergosterol

A

found mainly in fungal cell membranes, forms clusters within the phospholipid bilayer - role in regulating membrane permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how is ergosterol made?

A

squalene - lanosterol - ergosterol (squalene expoxidase & lanosterol 1,4 demethylase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is beta 1,3 glucans

A

50-60% dry weight of fungal cell wall - form a fibrous network on the inner surface o f the cell wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what enzyme synthesises beta-1,3-glucan?

A

beta-1,3-glucan synthase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the 6 different classes of antifungal drugs

A

polyenes, allylamines, azoles, echinocandins, 5-fluorocytosine, griseofuluin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA for polyene

A

cell membrane so ergosterol - form pores and so loss of membrane integrity and cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the 2 subclasses of polyene

A

amphotericin B & nystatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what fungi is amphotericin B be useful against

A

most fungi of medical interest - aspergillus spp. , Candida spp. cryptococcus spp.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are some of the adverse effect of amphotericin B

A

allergic & nephotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is an alternative of amphotericin B

A

liposomal amphotericin B - decreases nephrotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

route of administration for amphotercin B

A

parenterally - not absorbed orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

route of administration for nystatin

A

too toxic for systemic use, superficial infections only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA for allylamines

A

inhibit ergosterol synthesis - squalene epoxidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

example of allylamines

A

terbinafine

17
Q

adverse effect of allylamines

A

liver toxicity

18
Q

clinical use of allylamines

A

dermatophyte infectinos - topical use - athletes foot, systemic use - scalp ringworm

19
Q

MOA of azoles

A

inhibit ergosterol synthesis - lanesterol alpha14-demethylase (build up of non-ergosterol 14-sterol in cell membrane

20
Q

what are the 2 subclasses of azoles

A

imidazoles, triazole

21
Q

route of administration for both imidazole & triazole

A

imidazole - too toxic for systemic rarely used systemically

triazole - not as toxic, common systemic use

22
Q

an example for imidazole

A

clotrimazole

23
Q

examples of triazole

A

fluconazole, itraconazole, voriconazole

24
Q

adverse effects of azoles

A

hepatotoxicity, drug interaction - inhibit cytochrome p-450 enzyme

25
clinical use for imidazole
dermatophyte infections, candidiasis
26
clinical use for triazole
candidasis (fluconazole), aspergillosis
27
MOA for echinocandins
inhibition of beta-1.3-glucan synthase - constructino of abnormal cell wall
28
an example of echinocandins
anidulafungin
29
which organism will echinocandins work against
aspergillus and candida spp.
30
adverse effect echinocandins
minial
31
clinical use for echinocandins
systemic infection - parenteral formulation
32
MOA for 5-fluorocytosine
analogue of cytosine - inhibit RNA/protein synthesis & DNA synthesis
33
which organisms will 5-fluorocytosine work against
yeasts only - candida and cryptococcus spp.
34
adverse effects of 5-fluorocytosine
bone marrow suppression
35
clinical use for 5-fluorocytosine
cryptococcus meningitis (in combination with AmB)
36
MOA of Griseofulvin
inhibition of fungal mitosis
37
adverse effect of griseofulvin
minimal
38
clinical use of griseofulvin
dermatophyte infections in children requiring systemic treatment